1 / 17

Gene Therapy: Hemophilia and Beyond

Gene Therapy: Hemophilia and Beyond. By: Joel Rodriguez. What is Hemophilia. The royal disease Bleeding disorder Factors VIII and IX Current treatments – Pros and Cons Clean proteins. Image from: http ://static.ddmcdn.com/gif/blood-cells.jpg.

lois
Download Presentation

Gene Therapy: Hemophilia and Beyond

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Gene Therapy: Hemophilia and Beyond By: Joel Rodriguez

  2. What is Hemophilia • The royal disease • Bleeding disorder • Factors VIII and IX • Current treatments – Pros and Cons • Clean proteins Image from: http://static.ddmcdn.com/gif/blood-cells.jpg

  3. Images from: http://www.daviddarling.info/encyclopedia/H/hemophilia.html

  4. Symptoms • Symptoms may arise when damage is already great. • Profuse bleeding • Bruising • Joint swelling (Can be very extreme) • Simple wounds take longer than normal to stop bleeding

  5. Gene Therapy? • Different techniques • In vivo • Ex vivo • Target organs • Liver • Bone marrow • Stem cells • Muscular tissue • Introduce Viral DNA? Image from: http://www.cosmosmagazine.com/node/1024

  6. Gene Therapy? • Bad track record • Deaths in previous trials • Many problems with gene therapy • Immune system • Inhibitors • Cancer • Permanency?

  7. NY Times Article • British trial showing success • Patients blood factors sustainability improvements • Intravenous injections • Liver is focus • Cost • Standard treatment: upwards of $20 million in a lifetime • Gene therapy (if successful): Approx. $30,000 per injection

  8. NY Times Article • Makes use of adeno-associated virus • Less chance of DNA alteration • Some patients show great response • Less than the article would have you believe • Still not a permanent solution thus far • All comes back to the immune system

  9. Image from: http://upload.wikimedia.org/wikipedia/commons/3/3d/Gene_therapy.jpg

  10. Successes with Hemophilia • Recent successes with new techniques • Lab tests with mice and even dogs give hope • Most improvement with different types of immunosuppressant • Viral vector alone still has major effects. http://pavlovsape.files.wordpress.com/2010/06/lab-rat.jpg

  11. Liu, L., H. Liu, C. Mah, and B. S. Fletcher. "Indoleamine 2,3-dioxygenase Attenuates Inhibitor Development in Gene-therapy-treated Hemophilia A Mice." Gene Therapy 16.6 (2009): 724-33. Print.

  12. Possible applications • Potential use for many other diseases • HIV • Cancer • Diabetes • Not all techniques would work • Ones used now are only temporary

  13. Specific Example • Muscular dystrophy • Another disease that has high hopes with gene therapy • Currently using adeno-associated viruses (same as for hemophilia) • Study also tested different types of AAVs • Quite astonishing result (although temporary)

  14. Wang, Zhong, Tong Zhu, ChunpingQiao, Liqiao Zhou, Bing Wang, Jian Zhang, Chunlian Chen, Juan Li, and Xiao Xiao. "Adeno-associated Virus Serotype 8 Efficiently Delivers Genes to Muscle and Heart." Nature Biotechnology 23.3 (2005): 321-28. Print.

  15. Conclusion • Articles claim of breakthrough is way out of proportion • Still many problems to be tackled • Cell longevity and division reduces effectiveness • The more expensive ex vivo technique holds the key to longevity of cure • Very much worth pursuing for the betterment of mankind as a whole • Imagine a world free of disease

  16. Thanks for listening!Any questions may be asked now.

  17. Works Cited • Chuah, Marinee K. L., Desire Collen, and Thierry VandenDriessche. "Gene Therapy for Hemophilia." The Journal of Gene Medicine 3.1 (2001): 3-20. Print. • Liu, L., H. Liu, C. Mah, and B. S. Fletcher. "Indoleamine 2,3-dioxygenase Attenuates Inhibitor Development in Gene-therapy-treated Hemophilia A Mice." Gene Therapy 16.6 (2009): 724-33. Print. • Wang, Zhong, Tong Zhu, ChunpingQiao, Liqiao Zhou, Bing Wang, Jian Zhang, Chunlian Chen, Juan Li, and Xiao Xiao. "Adeno-associated Virus Serotype 8 Efficiently Delivers Genes to Muscle and Heart." Nature Biotechnology 23.3 (2005): 321-28. Print. • http://www.nytimes.com/2011/12/11/health/research/hemophilia-b-gene-therapy-breakthrough.html?_r=2&src=tp

More Related